Kappos L, et al. Efficacy and safety of ponesimod compared to teriflunomide in patients with relapsing multiple sclerosis: results of the randomized, active-controlled, double-blind, parallel-group phase 3 OPTIMUM study. Abstract 93. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Nederlandse Hersenbank: doodsoorzaak te vaak onjuist
apr 2017 | Bewegingsstoornissen, Dementie, Multipele Sclerose